Literature DB >> 25096540

Affective prosody perception in symptomatically remitted patients with schizophrenia and bipolar disorder.

Christine M Hoertnagl1, Nursen Yalcin-Siedentopf2, Susanne Baumgartner2, Falko Biedermann2, Eberhard A Deisenhammer1, Armand Hausmann1, Alexandra Kaufmann2, Georg Kemmler1, Moritz Mühlbacher3, Anna-Sophia Rauch2, Wolfgang W Fleischhacker4, Alex Hofer5.   

Abstract

Affect perception has frequently been shown to be impaired in patients suffering from schizophrenia or bipolar disorder (BD), but it remains unclear whether these impairments exist during symptomatic remission and whether the two disorders differ from each other in this regard. Most previous studies have investigated facial affect recognition, but not the ability to decode mental states from emotional tone of voice, i.e. affective prosody perception (APP). Accordingly, the present study directly compared APP in symptomatically remitted patients with schizophrenia or BD and healthy control subjects and investigated its relationship with residual symptomatology in patients. Patients with schizophrenia and BD showed comparable APP impairments despite being symptomatically remitted. In comparison to healthy control subjects, overall APP deficits were found in BD but not in schizophrenia patients. Both patient groups were particularly impaired in the identification of anger and confounded it with neutral prosody. In addition, schizophrenia patients frequently confused sadness with happiness, anger, or fright. There was an inverse association between the degree of residual positive symptoms and the ability to correctly recognize happiness in schizophrenia patients. Overall, these data indicate that impairments in APP represent an enduring deficit and a trait marker of both schizophrenia and BD and that the level of impairment is comparable between disorders.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Affective prosody perception; Bipolar disorder; Schizophrenia; Social cognition

Mesh:

Year:  2014        PMID: 25096540     DOI: 10.1016/j.schres.2014.07.019

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  7 in total

1.  Emotional intelligence and non-social cognition in schizophrenia and bipolar I disorder.

Authors:  B Frajo-Apor; G Kemmler; S Pardeller; T Plass; M Mühlbacher; A-S Welte; W W Fleischhacker; A Hofer
Journal:  Psychol Med       Date:  2016-09-19       Impact factor: 7.723

2.  Neurophysiological Evidence of Compensatory Brain Mechanisms Underlying Attentional-Related Processes in Symptomatically Remitted Patients with Schizophrenia.

Authors:  Guoliang Chen; Weiyan Ding; Lei Zhang; Hong Cui; Zhongdong Jiang; Yansong Li
Journal:  Front Psychol       Date:  2017-04-20

3.  CACNA1C risk variant affects microstructural connectivity of the amygdala.

Authors:  Katharina Koch; Sophia Stegmaier; Lena Schwarz; Michael Erb; Mara Thomas; Klaus Scheffler; Dirk Wildgruber; Vanessa Nieratschker; Thomas Ethofer
Journal:  Neuroimage Clin       Date:  2019-03-12       Impact factor: 4.881

4.  Social Cognition Analyzer Application-A New Method for the Analysis of Social Cognition in Patients Diagnosed With Schizophrenia.

Authors:  Eszter Varga; Róbert Herold; Tamás Tényi; Szilvia Endre; Judit Fekete; Titusz Bugya
Journal:  Front Psychiatry       Date:  2019-12-20       Impact factor: 4.157

Review 5.  Emotional Prosody Processing in Schizophrenic Patients: A Selective Review and Meta-Analysis.

Authors:  Yi Lin; Hongwei Ding; Yang Zhang
Journal:  J Clin Med       Date:  2018-10-17       Impact factor: 4.241

6.  Improving emotion recognition in schizophrenia with "VOICES": An on-line prosodic self-training.

Authors:  María Lado-Codesido; Cristina Méndez Pérez; Raimundo Mateos; José Manuel Olivares; Alejandro García Caballero
Journal:  PLoS One       Date:  2019-01-25       Impact factor: 3.240

7.  Theory of mind in remitted bipolar disorder: Interpersonal accuracy in recognition of dynamic nonverbal signals.

Authors:  Usue Espinós; Enrique G Fernández-Abascal; Mercedes Ovejero
Journal:  PLoS One       Date:  2019-09-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.